$XOMA

LIMBER JOSEPH M sold (to issuer) 30,000 shares of XOMA

LIMBER JOSEPH M sold (to issuer) 30,000 shares of XOMA Royalty Corp (XOMA) across 2 trades on 2026-07-14.

Original reporting
SEC EDGAR · LIMBER JOSEPH M
Published Jul 15, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 2:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$XOMA
Neutral
high confidence
Mentioned
$XOMA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XOMANeutralLow
01

Why it matters

The filing discloses the number of shares sold to the issuer but does not provide price, value, or any new company-specific fundamental information.

02

Market read

Traders may note insider activity, but the lack of disclosed price and absence of other catalysts makes it low-impact.

03

What to watch

Because the price is not disclosed and the code indicates sale to issuer, the signal-to-noise for interpreting insider sentiment is low.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-14 for a sale to issuer dated 2026-07-14.

Background

This is an SEC Form 4 insider transaction disclosure for XOMA Royalty Corp, reported by a director.

Company-level read

Ticker impact

$XOMANeutralHigh confidence
Context

XOMA director Limber Joseph M sold 30,000 shares to the issuer via two trades on 2026-07-14, with price undisclosed.

Expected impact

Minimal near-term impact; any reaction would be small and short-lived unless paired with other disclosures.

Evidence & confidence

Form 4 shows a director sale to issuer, but provides no transaction price or new operating/regulatory/financial catalyst in the text.

Market effects

No sector read-through; this is a single-company insider transaction with no new guidance or trial/regulatory update.

None indicated.

None indicated.

Counterpoint

The sale could reflect liquidity needs or planned disposition rather than bearish views, so it may not warrant any directional trade.

Key entities

  • XOMA Royalty Corp

    Company whose director insider sale to issuer is reported on Form 4.

  • LIMBER JOSEPH M

    Director who sold 30,000 shares to the issuer on 2026-07-14.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LGNDMedAI 9/10

XOMA Royalty Announces Closing of Its Acquisition by Ligand

XOMA Royalty said Ligand Pharmaceuticals (Nasdaq: LGND) completed its acquisition of XOMA Royalty. Under the April 27 deal, XOMA shareholders received $39.00 cash per share and one non-transferable CVR per share tied to 75% of net proceeds from certain pending litigation. XOMA shares no longer trade on Nasdaq.

$LAURMed

Snow Ian Kendell sold $19.1M of LAUR (indirect holdings)

Snow Ian Kendell sold 521,229 indirectly-held shares of LAUREATE EDUCATION, INC. (LAUR) at an average of $36.65 ($36.26–$38.43, $19.10M total) across 3 trades over 2026-08-31 to 2026-09-02. Filed jointly with Snow Phipps Group (RPV), L.P. (Director), Snow Phipps Group (Offshore), L.P. (Director), SPG Co-Investment, L.P. (Director), Snow Phipps Group (B), L.P. (Director), Snow Phipps Group, L.P. (Director) and Snow Phipps Group, LLC (Director).